Navigation Links
Amifostine Renders Cancer More Susceptible To Radiation

The drug amifostine has been found to ease most of the side affects associated with radiation therapy and also make cancer more susceptible to radiation, according to doctors in Brazil. Their findings are published in the March 1// issue of the International Journal of Radiation

Oncology*Biology*Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology. The reserachers decided to check out data from already published studies to evaluate if adding amifostine to radiation therapy decreased the occurrence of side effects like difficulty in swallowing, dry mouth, lung inflammation, bladder inflammation, problems with the esophagus and inflammation of the mucous membranes. Sometimes these side effects cause significant problems and even force the treatment to be stopped while the patient recovers. The study also wanted to find out if amifostine protected the cancer from radiation. The researchers evaluated the effects of amifostine in 14 randomized, controlled trials in which 1,451 patients were enrolled. These patients were split into two groups, one receiving radiation alone, while the other received radiation as well as amifostine. It was found that contrary to fears, amifostine rendered the tumor more susceptible to radiation and patients on amifostine were more likely to have their cancer completely cured by radiation. But amifostine did have some side effects like nausea and vomiting. "Our research shows that adding amifostine to radiation therapy helps reduce side effects while at the same time making the radiation treatments more effective at killing the cancer cells," said Andre Deeke Sasse, M.D., a radiation oncologist at Nucleo Brasileiro de Oncologia Baseada em Evidencias in Sao Paolo, Brazil. "We recommend that patients undergoing radiation therapy for cancer ask their doctor about adding amifostine to their treatment." For more information on radiation therapy for cancer, please visit www.rtanswers.org. Contact: Nick Lashinsky nickl@astro.org 703-227-0185 American Society for Therapeutic Radiology and Oncology Source: Eurekalert
'"/>




Related medicine news :

1. Anthrax Spores: Animal Skins on Drums, Renders Vado Diomande, Sick
2. Fibroids unlikely to Turn Cancerous
3. Virus Level could Predict Cervical Cancer Risk
4. Cancer Doctors Okays Controversial Prostate Therapy
5. Potential New Cancer Gene Identified
6. Consensus on "Combination Therapy" for Breast Cancer
7. Cancers of Colon & Rectum linked to Cigarette Smoking
8. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
9. The Cancer Rumour mill working over time
10. Cancer drugs in development nearly doubled since 1995
11. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2017)... ... ... Dr. Manju R. Kejriwal, a leading Ohio dentist, is now welcoming new ... Dr. Kejriwal understands the emotional and financial toll traditional orthodontics can take on patients’ ... longer need to feel the esthetic effects of wires and brackets when they can ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... female reproductive tract in which the endometrial lining of the uterus spreads ... and pain. Patients experiencing painful intercourse, painful periods, pelvic pain, or irregular ...
(Date:5/24/2017)... , ... May 24, 2017 , ... Rob Lowe is ... “Informed,” developed for Public Television. “Informed” brings the public important topics from all aspects ... treatment of the feet and issues surrounding feet and ankles. , Podiatry is essential ...
(Date:5/23/2017)... ... May 23, 2017 , ... MDLand International (MDLand), a leading ... that its iClinic V12.2 solution has achieved approval from National Center for Quality ... 2017 standards which emphasize team-based care with a significant focus on the care ...
(Date:5/23/2017)... ... , ... New England Journal Of Medicine Confirms Viability of Rory’s Regulations and ... Staunton Foundation Calls on Health & Human Services, Tom Price to Adopt Rory’s Regulations ... today reported on a new study released on May 21, 2017 in the New ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... MAITLAND, Fla. , May 22, 2017 /PRNewswire/ ... industry as a whole continue to make the ... evidence becomes increasingly important for ensuring positive patient ... Key industry stakeholders are shifting focus away from ... results and effects of long-term specialty drug therapy ...
(Date:5/15/2017)... May 15, 2017  Amy Baxter MD, chief executive ... in noninvasive pain relief, was awarded a 2017 Top ... Baxter was recognized at the MM&M Top 40 Healthcare ... City on May 10, 2017. The dinner ... industry go "beyond the pill."  "Innovation goes ...
(Date:5/11/2017)... , May 11, 2017  Thornhill Research Inc. ... been awarded an $8,049,024 USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery ... the Canadian Commercial Corporation (CCC) ( Ottawa, ... Systems to administer general anesthesia to patients requiring ... "The US Marine Corps have been a ...
Breaking Medicine Technology: